Acanthosis nigricans following single lung transplantation: a case report

Prog Transplant. 2006 Sep;16(3):239-41. doi: 10.1177/152692480601600309.

Abstract

Acanthosis nigricans was observed 3 months after single lung transplantation in a 51-year-old African American woman with idiopathic pulmonary fibrosis. The patient had no endocrinological abnormalities and was not taking any medications known to cause acanthosis nigricans; extensive investigation did not reveal an underlying malignant process. Because acanthosis nigricans may occur as a paraneoplastic phenomenon, it is important to rule out an underlying malignancy. This is especially important in solid-organ transplant recipients receiving chronic immunosuppressive therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acanthosis Nigricans / diagnosis
  • Acanthosis Nigricans / epidemiology
  • Acanthosis Nigricans / etiology*
  • Black or African American / statistics & numerical data
  • Diagnosis, Differential
  • Eyelid Diseases / diagnosis
  • Eyelid Diseases / epidemiology
  • Eyelid Diseases / etiology
  • Female
  • Hand Dermatoses / diagnosis
  • Hand Dermatoses / epidemiology
  • Hand Dermatoses / etiology
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Lung Transplantation / adverse effects*
  • Lung Transplantation / immunology
  • Middle Aged
  • Obesity / complications
  • Paraneoplastic Syndromes / diagnosis
  • Paraneoplastic Syndromes / etiology
  • Pulmonary Fibrosis / surgery
  • Risk Factors

Substances

  • Immunosuppressive Agents